<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Sclerema neonatorum
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Sclerema neonatorum
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Sclerema neonatorum
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Raegan Hunt, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Moise L Levy, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rosamaria Corona, MD, DSc
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 05, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H2963680262">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sclerema neonatorum is an uncommon, severe panniculitis that manifests as diffuse skin hardening in critically ill, premature and low birth weight infants [
         <a href="#rid1">
          1
         </a>
         ]. Skin and subcutaneous fat become bound down and adherent to underlying muscle and bone, such that critical functions of breathing, feeding, and movement can be impeded. Affected newborns typically suffer from comorbid conditions, including sepsis, dehydration, intracranial hemorrhage, severe respiratory or gastrointestinal disease, and congenital malformations. Mortality rates among cases of sclerema neonatorum are high; however, with modern neonatal intensive care resources, sclerema neonatorum is uncommon. Regardless, rare cases of sclerema neonatorum continue to be reported [
         <a href="#rid2">
          2
         </a>
         ], and it is important that clinicians can diagnose and treat this entity.
        </p>
        <p>
         This topic reviews the pathogenesis, clinical manifestations, diagnosis, and management of sclerema neonatorum. Subcutaneous fat necrosis of the newborn is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13738.html" rel="external">
          "Subcutaneous fat necrosis of the newborn"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3831612679">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The incidence of sclerema neonatorum is not known. The largest case series describing sclerema neonatorum were published between 1940 and 1970 [
         <a href="#rid3">
          3
         </a>
         ]. Aggregation of case reports suggests that males may be affected slightly more often than females (male-to-female ratio, 1.6:1) [
         <a href="#rid1">
          1
         </a>
         ]. Maternal parity does not appear to be a risk factor [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         It is hypothesized that improved perinatal intensive care has substantially reduced the number of infants affected by sclerema neonatorum, rendering sclerema neonatorum an uncommon diagnosis in the setting of modern neonatal intensive care [
         <a href="#rid5">
          5
         </a>
         ]. Limited data suggest that the incidence of sclerema neonatorum may be higher in areas with less access to high acuity neonatal care. A study evaluating premature newborns at a tertiary pediatric hospital in Bangladesh from 1998 to 2003 reported a 10 percent incidence of sclerema neonatorum [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3320910532">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pathogenesis of sclerema neonatorum remains unknown. Subcutaneous adipose tissue in neonates is enriched in saturated fats compared with the subcutaneous fat composition of older individuals. This biochemical property of subcutaneous fat makes it more likely to harden in a cold environment. It has been suggested that decreased body temperature encountered in clinical shock triggers subcutaneous adipose hardening in sclerema neonatorum [
         <a href="#rid7">
          7
         </a>
         ]. However, fat hardening should not occur until skin temperature is below the freezing point, which argues against this explanation. Alternative theories propose that sclerema neonatorum is a consequence of abnormal fat metabolism, results from dysfunction of the connective tissue surrounding the adipocytes, or is a downstream effect triggered by systemic toxicity [
         <a href="#rid8">
          8-10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4242263172">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sclerema neonatorum characteristically affects newborn infants and typically develops within the first week of life, although a few cases have been reported to occur beyond the neonatal period. Affected newborns typically suffer from comorbid conditions, including sepsis, dehydration, intracranial hemorrhage, severe respiratory or gastrointestinal disease, and congenital malformations.
        </p>
        <p>
         The skin is waxy appearing, tight, and adherent to underlying tissues. In some infants, the skin appears purple or mottled. The skin cannot be lifted, pinched, or depressed. Sclerema neonatorum classically develops symmetrically on the trunk, thighs, or buttocks, and then the skin hardening quickly spreads to involve the subcutaneous fat of the entire body (except for the fat-free areas of the genitalia, palms, and soles). Hardening of the facial skin may manifest as a mask-like, fixed facies.
        </p>
        <p>
         Skin tightening limits chest wall expansion and respiration, and it may also restrict feeding and other movements. Joint contractures are frequently noted. Compartment syndrome of an extremity in sclerema neonatorum has been described [
         <a href="#rid11">
          11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/358.html" rel="external">
          "Acute compartment syndrome of the extremities"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H526907461">
         <span class="h1">
          DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H1151785602">
         <span class="h2">
          Clinical
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of sclerema neonatorum is made clinically, based upon the observation of diffuse skin hardening in a gravely ill newborn. The affected skin is fixed to underlying tissue and cannot be folded, pinched, or pitted. If the diagnosis is in question, skin biopsy may offer histopathologic support to the diagnosis. (See
         <a class="local">
          'Pathology'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H318472075">
         <span class="h2">
          Pathology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Histopathologic findings of sclerema neonatorum include [
         <a href="#rid5">
          5,12
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Necrosis of subcutaneous fat without significant inflammatory infiltrate and with no prominent granulomatous changes
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Formation of needle-shaped clefts in adipocytes, sometimes in a radial arrangement
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fibrous thickening of tissue surrounding fat lobules
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2855598488">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H3767869358">
         <span class="h2">
          Subcutaneous fat necrosis of the newborn
         </span>
         <span class="headingEndMark">
          —
         </span>
         Subcutaneous fat necrosis of the newborn typically presents around one to four weeks of life as circumscribed, red-brown, firm plaques in healthy-term or post-term neonates (
         <a class="graphic graphic_picture graphicRef83790" href="/z/d/graphic/83790.html" rel="external">
          picture 1
         </a>
         ). As opposed to sclerema neonatorum, lesions tend to remain localized and develop later in life; although firm, the affected skin freely moves over the underlying tissue (
         <a class="graphic graphic_table graphicRef70556" href="/z/d/graphic/70556.html" rel="external">
          table 1
         </a>
         ). Risk factors for subcutaneous fat necrosis of the newborn include hypoxia, perinatal distress, and therapeutic hypothermia [
         <a href="#rid13">
          13,14
         </a>
         ]. On histopathology, subcutaneous fat necrosis of the newborn demonstrates fat necrosis and a robust, inflammatory infiltrate including histiocytes, eosinophils, and multinucleated giant cells. Crystal cleft spaces similar to those in sclerema neonatorum may be observed within adipocytes, and calcification may be present [
         <a href="#rid5">
          5,12
         </a>
         ]. The clinical findings and the extensive, inflammatory infiltrate on histopathology encountered in subcutaneous fat necrosis of the newborn help to distinguish it from sclerema neonatorum. (See
         <a class="medical medical_review" href="/z/d/html/13738.html" rel="external">
          "Subcutaneous fat necrosis of the newborn"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2284461442">
         <span class="h2">
          Cold panniculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cold panniculitis is characterized by erythematous, firm, well-demarcated plaques that develop at sites where the skin has been subjected to cold temperatures (
         <a class="graphic graphic_picture graphicRef83785" href="/z/d/graphic/83785.html" rel="external">
          picture 2
         </a>
         ) [
         <a href="#rid13">
          13
         </a>
         ]. It appears within hours to a few days after cold exposure and resolves spontaneously. Cases of cold panniculitis in infants have been reported after application of ice to the face to treat supraventricular tachycardia and after use of cooling blankets during cardiac surgery [
         <a href="#rid15">
          15
         </a>
         ]. Whereas the clinical findings may be very similar, the histopathology of cold panniculitis lacks the characteristic needle-shaped clefts observed in subcutaneous fat necrosis of the newborn or sclerema neonatorum, and cystic spaces are often apparent where fat cells have presumably ruptured [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H873190600">
         <span class="h2">
          Scleredema
         </span>
         <span class="headingEndMark">
          —
         </span>
         Scleredema has been rarely described among infants exposed to cold temperatures or those with severe diarrhea or infection during the first week of life [
         <a href="#rid16">
          16,17
         </a>
         ]. Affected skin in neonatal scleredema is visibly thickened and wax like. The legs are involved more frequently than other body sites. In contrast to sclerema neonatorum, the skin is edematous and exhibits easy pitting [
         <a href="#rid1">
          1
         </a>
         ]. Histopathology shows edema of the dermis and subcutaneous fat and lymphohistiocytic inflammation of the fat lobules.
        </p>
        <p>
         Scleredema in adults (scleredema adultorum of Buschke) differs from that described in infants. Scleredema adultorum is associated with increased mucin disposition and thickened collagen. (See
         <a class="medical medical_review" href="/z/d/html/89274.html" rel="external">
          "Scleredema"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2552337897">
         <span class="h2">
          Restrictive dermopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Restrictive dermopathy is a lethal genetic disease characterized by abnormally tight skin from birth. Affected newborns are usually premature and have diffusely hard skin that may shear or tear at areas of skin folding, such as the neck, inguinal folds, and lower abdomen (
         <a class="graphic graphic_picture graphicRef110284 graphicRef112139" href="/z/d/graphic/110284.html" rel="external">
          picture 3A-B
         </a>
         ). Additional clinical findings include joint contractures, ectropion, chest wall narrowing, hypoplastic clavicles, and a fixed O-shaped mouth. This condition is associated with polyhydramnios and pulmonary hypoplasia and is generally fatal in the newborn period. Histopathology shows flattened rete ridges, a thin dermis with horizontally oriented collagen, and incompletely developed skin appendages [
         <a href="#rid18">
          18
         </a>
         ]. Recessive mutations in
         <em>
          ZMPSTE24
         </em>
         , which encodes a zinc metalloproteinase that processes the important nuclear envelope protein lamin A (encoded by
         <em>
          LMNA)
         </em>
         , are responsible for most cases; however, dominant
         <em>
          LMNA
         </em>
         mutations have been found in restrictive dermopathy as well [
         <a href="#rid19">
          19,20
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10192637">
         <span class="h2">
          Hutchinson-Gilford progeria syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sclerodermatous skin tightening has been uncommonly reported in infants with Hutchinson-Gilford progeria, with the youngest reported affected child being approximately two weeks of age [
         <a href="#rid21">
          21
         </a>
         ]. Findings of prominent skin veins, alopecia, frontal bossing, bird-like nose, and micrognathia support the diagnosis. Skin biopsy typically demonstrates thickened dermal collagen but is nonspecific. Most cases are due to an autosomal dominant
         <em>
          LMNA
         </em>
         mutation [
         <a href="#rid22">
          22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/106741.html" rel="external">
          "Hutchinson-Gilford progeria syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2022733587">
         <span class="h1">
          MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnosis and treatment of concurrent illnesses is paramount for infants affected by sclerema neonatorum. Infections, metabolic disturbance, cardiac disease, and other congenital malformations must be treated promptly. Body temperature, fluid status, and electrolyte levels should be monitored and actively maintained within normal ranges.
        </p>
        <p>
         In the 1960s and 1970s, the use of systemic corticosteroids for sclerema neonatorum did not appear to improve survival, although in some cases, systemic corticosteroids may have limited the expansion of existing lesions [
         <a href="#rid4">
          4,23-25
         </a>
         ]. A 2017 case report describes successful treatment of a 1550 g preterm infant with progressive sclerema neonatorum in the context of hypoglycemia and sepsis with parenteral
         <a class="drug drug_pediatric" data-topicid="13361" href="/z/d/drug information/13361.html" rel="external">
          hydrocortisone
         </a>
         , antibiotics, and supportive intensive care management [
         <a href="#rid26">
          26
         </a>
         ]. However, additional study is needed to determine the efficacy of systemic corticosteroids for treatment of sclerema neonatorum in the context of modern neonatal intensive care practices.
        </p>
        <p>
         Exchange transfusion has been utilized in the treatment of sclerema neonatorum [
         <a href="#rid27">
          27-29
         </a>
         ]. One randomized clinical study that included 40 newborns with sepsis and sclerema neonatorum reported 50 percent mortality in infants treated with exchange transfusion versus 95 percent in untreated infants [
         <a href="#rid27">
          27
         </a>
         ]. In a single case report, intravenous immunoglobulin infusion in a full-term infant with biopsy-proven sclerema neonatorum induced a transitory, mild clinical improvement of the skin, although the child died of respiratory failure secondary to chest wall skin tightening at six weeks of age [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2969074951">
         <span class="h1">
          PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sclerema neonatorum is associated with a high mortality rate. Case series estimate that 13 to 39 percent of affected neonates survive [
         <a href="#rid1">
          1
         </a>
         ]. Among survivors, there are generally no long-term skin complications [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2661110140">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         – Sclerema neonatorum is an uncommon, severe, diffuse panniculitis that develops in critically ill neonates. Premature and low birth weight infants are the most susceptible. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Affected skin in sclerema neonatorum is waxy, tight, and adherent to underlying tissues. Skin hardening develops symmetrically on the trunk, thighs, and buttocks but quickly spreads to involve the entire body symmetrically, sparing the areas that lack subcutaneous fat (eg, palms, soles, and genitalia). Affected infants typically suffer from comorbid disease, including sepsis, congenital malformations, and severe respiratory or gastrointestinal illness. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – Sclerema neonatorum is typically diagnosed clinically. If the diagnosis is uncertain, a skin biopsy may be helpful for confirmation. On histopathology, sclerema neonatorum shows needle-shaped clefts in adipocytes and fibrotic change around fat lobules without significant inflammation or granulomatous infiltrate. (See
         <a class="local">
          'Diagnosis'
         </a>
         above and
         <a class="local">
          'Pathology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
         – As sclerema neonatorum develops within the context of serious illness (most often in premature and low birth weight neonates), prompt diagnosis and treatment of associated disease is critical. Limited available data suggest that exchange transfusion may help reduce mortality in affected infants. (See
         <a class="local">
          'Management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prognosis
         </strong>
         – Sclerema neonatorum is associated with a high mortality rate. Based on case series, it is estimated that 13 to 39 percent of affected neonates survive. (See
         <a class="local">
          'Prognosis'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Zeb A, Darmstadt GL. Sclerema neonatorum: a review of nomenclature, clinical presentation, histological features, differential diagnoses and management. J Perinatol 2008; 28:453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spohn GP, Pietras TA, Stone MS. Delayed-Onset Sclerema Neonatorum in a Critically Ill Premature Infant. Pediatr Dermatol 2016; 33:e168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polcari IC, Stein SL. Panniculitis in childhood. Dermatol Ther 2010; 23:356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           KHETARPAL SK, SUBRAHMANYAM VV. SCLEREMA NEONATORUM: A STUDY OF 17 CASES. Indian J Pediatr 1964; 31:8.
          </a>
         </li>
         <li class="breakAll">
          Weedon D. Panniculitis. In: Weedon's Skin Pathology, 3rd ed, Weedon D (Ed), Churchill Livingstone/Elsevier, 2010. p.1041.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zeb A, Rosenberg RE, Ahmed NU, et al. Risk factors for sclerema neonatorum in preterm neonates in Bangladesh. Pediatr Infect Dis J 2009; 28:435.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           HUGHES WE, HAMMOND ML. Sclerema neonatorum. J Pediatr 1948; 32:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kellum RE, Ray TL, Brown GR. Sclerema neonatorum. Report of a case and analysis of subcutaneous and epidermal-dermal lipids by chromatographic methods. Arch Dermatol 1968; 97:372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           WARWICK WJ, RUTTENBERG HD, QUIE PG. Sclerema neonatorum--a sign, not a disease. JAMA 1963; 184:680.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Villacorte G, Frank DJ. Sclerema neonatorum. A report of nine cases. Ohio State Med J 1967; 63:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Christiansen SD, Desai NS, Pulito AR, Slack MR. Ischemic extremities due to compartment syndromes in a septic neonate. J Pediatr Surg 1983; 18:641.
          </a>
         </li>
         <li class="breakAll">
          Rapini RP. Practical Dermatopathology, 1st ed, Elsevier Mosby, 2005.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hogeling M, Meddles K, Berk DR, et al. Extensive subcutaneous fat necrosis of the newborn associated with therapeutic hypothermia. Pediatr Dermatol 2012; 29:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Del Pozzo-Magaña BR, Ho N. Subcutaneous Fat Necrosis of the Newborn: A 20-Year Retrospective Study. Pediatr Dermatol 2016; 33:e353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Markus JR, de Carvalho VO, Abagge KT, Percicotte L. Ice age: a case of cold panniculitis. Arch Dis Child Fetal Neonatal Ed 2011; 96:F200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heilbron B, Saxe N. Scleredema in an infant. Arch Dermatol 1986; 122:1417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar R, Agarwal PK, Wakhlu AK, Wakhlu I. Scleredema in a 6-week-old baby. Indian Pediatr 1991; 28:1195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smitt JH, van Asperen CJ, Niessen CM, et al. Restrictive dermopathy. Report of 12 cases. Dutch Task Force on Genodermatology. Arch Dermatol 1998; 134:577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Navarro CL, Esteves-Vieira V, Courrier S, et al. New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update. Eur J Hum Genet 2014; 22:1002.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKenna T, Sola Carvajal A, Eriksson M. Skin Disease in Laminopathy-Associated Premature Aging. J Invest Dermatol 2015; 135:2577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Darragh CT, Eichel Y, Lewis FJ, et al. Sclerodermatous skin changes in an infant. Pediatr Dermatol 2014; 31:387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gonzalo S, Kreienkamp R. DNA repair defects and genome instability in Hutchinson-Gilford Progeria Syndrome. Curr Opin Cell Biol 2015; 34:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bwibo NO, Anderson BT. Sclerema neonatorum (a study of 16 cases in the special care unit, Mulago Hospital, Kampala). East Afr Med J 1970; 47:50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LEVIN SE, BAKST CM, ISSEROW L. Sclerema neonatorum treated with corticosteroids. Br Med J 1961; 2:1533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milunsky A, Levin SE. Sclerema neonatorum: a clinical study of 79 cases. S Afr Med J 1966; 40:638.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shrestha S, Chaudhary N, Koirala S, Gupta R. Sclerema Neonatorum Treated Successfully with Parenteral Steroids: An Experience from a Resource Poor Country. Case Rep Pediatr 2017; 2017:4836142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sadana S, Mathur NB, Thakur A. Exchange transfusion in septic neonates with sclerema: effect on immunoglobulin and complement levels. Indian Pediatr 1997; 34:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xanthou M, Xypolyta A, Anagnostakis D, et al. Exchange transfusion in severe neonatal infection with sclerema. Arch Dis Child 1975; 50:901.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vain NE, Mazlumian JR, Swarner OW, Cha CC. Role of exchange transfusion in the treatment of severe septicemia. Pediatrics 1980; 66:693.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buster KJ, Burford HN, Stewart FA, et al. Sclerema neonatorum treated with intravenous immunoglobulin: a case report and review of treatments. Cutis 2013; 92:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Requena L, Yus ES. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol 2001; 45:163.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 13737 Version 9.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18368059" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Sclerema neonatorum: a review of nomenclature, clinical presentation, histological features, differential diagnoses and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27001336" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Delayed-Onset Sclerema Neonatorum in a Critically Ill Premature Infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20666823" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Panniculitis in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14116596" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : SCLEREMA NEONATORUM: A STUDY OF 17 CASES.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14116596" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : SCLEREMA NEONATORUM: A STUDY OF 17 CASES.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19319014" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Risk factors for sclerema neonatorum in preterm neonates in Bangladesh.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18866936" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Sclerema neonatorum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5643234" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Sclerema neonatorum. Report of a case and analysis of subcutaneous and epidermal-dermal lipids by chromatographic methods.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13999025" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Sclerema neonatorum--a sign, not a disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6037143" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Sclerema neonatorum. A report of nine cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6644514" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Ischemic extremities due to compartment syndromes in a septic neonate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6644514" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Ischemic extremities due to compartment syndromes in a septic neonate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21906137" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Extensive subcutaneous fat necrosis of the newborn associated with therapeutic hypothermia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27574011" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Subcutaneous Fat Necrosis of the Newborn: A 20-Year Retrospective Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21242244" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Ice age: a case of cold panniculitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3789776" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Scleredema in an infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1797676" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Scleredema in a 6-week-old baby.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9606327" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Restrictive dermopathy. Report of 12 cases. Dutch Task Force on Genodermatology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24169522" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26290387" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Skin Disease in Laminopathy-Associated Premature Aging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24758207" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Sclerodermatous skin changes in an infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26079711" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : DNA repair defects and genome instability in Hutchinson-Gilford Progeria Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5436180" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Sclerema neonatorum (a study of 16 cases in the special care unit, Mulago Hospital, Kampala).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14464580" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Sclerema neonatorum treated with corticosteroids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5949966" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Sclerema neonatorum: a clinical study of 79 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28584673" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Sclerema Neonatorum Treated Successfully with Parenteral Steroids: An Experience from a Resource Poor Country.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9251276" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Exchange transfusion in septic neonates with sclerema: effect on immunoglobulin and complement levels.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1211965" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Exchange transfusion in severe neonatal infection with sclerema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7432874" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Role of exchange transfusion in the treatment of severe septicemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24087781" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Sclerema neonatorum treated with intravenous immunoglobulin: a case report and review of treatments.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11464178" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Panniculitis. Part I. Mostly septal panniculitis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
